✉news ScienceBiology first seen 19 h ago, last 17 h ago, peak #37
Will whole genome sequencing replace targeted panels?
Drug Discovery News is asking whether whole genome sequencing will replace targeted genetic panels in clinical and research settings. The question touches an ongoing debate in genomics: sequencing costs have fallen sharply, but targeted panels remain cheaper and easier to interpret. No specific study or announcement is cited, so the discussion appears to be a general outlook piece rather than a report of a new development.
Why now: Falling sequencing costs are reviving debate over whether broad whole genome approaches should supplant narrower diagnostic panels.
Evidence
- Will whole genome sequencing replace targeted panels? · Drug Discovery News
API: https://socialmediatrends-api.osmike.com/v1/trends/3269507